Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Olschewski, H.
Current recommendations for the diagnosis and treatment of pulmonary hypertension
Dtsch Med Wochenschr. 2006; 131(49 Suppl 9):S334-S337
Doi: 10.1055/s-2006-957206
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Leading authors Med Uni Graz
- Olschewski Horst
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Spiroergometry and Doppler stress echocardiography are recommended in cases of suspected but unproven pulmonary hypertension (PHT). Treatment of the underlying disease is indicated when there is pulmonary hypertension associated with disease of the left heart or the lungs. Surgery is indicated if there if the PHT is caused by chronic thromboembolism. PAH patients in NYHA class III-IV who do not meet response criteria to acute vasodilators, can be treated with prostanoids, endothelin receptor antagonists or phosphodiesterase 5 inhibitors.
- Find related publications in this database (using NLM MeSH Indexing)
- 3',5'-Cyclic-GMP Phosphodiesterases - antagonists and inhibitors
- Algorithms - antagonists and inhibitors
- Antihypertensive Agents - therapeutic use
- Calcium Channel Blockers - therapeutic use
- Cyclic Nucleotide Phosphodiesterases, Type 5 - therapeutic use
- Echocardiography, Doppler - methods
- Echocardiography, Stress - methods
- Endarterectomy - methods
- Ergometry - methods
- Heart Failure - complications
- Humans - complications
- Hypertension, Pulmonary - diagnosis
- Lung Diseases - complications
- Prostaglandins - therapeutic use
- Pulmonary Embolism - complications
- Receptors, Endothelin - antagonists and inhibitors
- Vasodilator Agents - therapeutic use
- Ventricular Dysfunction, Left - complications
- Ventricular Dysfunction, Right - complications